Skip to content

Study · Case report or series · n = 3 · 2000

2 results

Growth hormone deficiency as the only identifiable cause for primary amenorrhea

Lee M

Journal of pediatric and adolescent gynecology1 May 2000Cited by 5 (Europe PMC)

PMID10869982 (opens in a new tab)DOI10.1016/s1083-3188(00)00025-5 (opens in a new tab)PepBankPUB-10869982
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanCase report or seriesActivity measurement

    In three adolescent females with isolated growth hormone deficiency, peak LH after intravenous gonadorelin was 19.0 to 56.1 mIU/ml.

    In plain wordsIn three young women with growth hormone deficiency, LH rose to 19.0 to 56.1 mIU/ml after intravenous gonadorelin.

    Peptide
    Gonadorelin (GnRH, LHRH)
    Outcome
    IncreasePeak LH after gonadorelin
    Study

    n = 3

    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    Dose not stated · intravenousAs given in this study (human).

    Measurements

    Peak LH
    19 to 56.1 mIU/ml
    after gonadorelin

    Source sentences

    Summary
    Peak LH after intravenous gonadrelin (FACTREL) were 19.0 to 56.1 mIU/ml
    1 context sentence
    Summary · context
    All of the 3 patients underwent combined pituitary function test.
  2. 02HumanCase report or seriesActivity measurement

    In three adolescent females with isolated growth hormone deficiency, LH percent responses to intravenous gonadorelin were 217 to 1100%, so gonadotropin deficiency was excluded.

    In plain wordsIn three young women with growth hormone deficiency, LH rose by 217 to 1100% after gonadorelin, which showed enough gonadotropin release.

    Peptide
    Gonadorelin (GnRH, LHRH)
    Outcome
    IncreaseLH percent response after gonadorelin
    Study

    n = 3

    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    Dose not stated · intravenousAs given in this study (human).

    Measurements

    LH percent response
    217 to 1100%
    after gonadorelin

    Source sentences

    Summary
    Peak LH after intravenous gonadrelin (FACTREL) were 19.0 to 56.1 mIU/ml and LH % responses were 217 to 1100% and were hence defined as not being gonadotropin deficiency.
    1 context sentence
    Summary · context
    All of the 3 patients underwent combined pituitary function test.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.